Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): A balancing act

被引：69

作者：

Burgoyne, Robert W. ^{[1
,2
]}

Tan, Darrell H. S. ^{[3
]}

机构：

[1] Univ Toronto, Immunodeficiency Clin, Univ Hlth Network, Toronto, ON M5G 2C4, Canada

[2] Univ Toronto, Dept Psychiat, Toronto, ON M5G 2C4, Canada

[3] Univ Toronto, Div Infect Dis, Toronto, ON M5G 2C4, Canada

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2008年 / 61卷 / 03期

关键词：

AIDS; drug toxicities; QOL;

D O I：

10.1093/jac/dkm499

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Advances in highly active antiretroviral therapy (HAART) options for people living with HIV/AIDS have resulted in decreased morbidity and mortality. To some extent, the role of disease progression in eroding quality of life (QOL) erosion in the pre-HAART age is now supplanted by drug toxicities, one of the Achilles' heels of HAART. This article reviews research findings on treatment and QOL outcomes a decade into the HAART era.

引用

页码：469 / 473

页数：5

共 65 条

[41] A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals [J].

Power, R ;

Tate, HL ;

McGill, SM ;

Taylor, C .

SEXUALLY TRANSMITTED INFECTIONS, 2003, 79 (02) :137-141

[42] Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment [J].

Préau, M ;

Leport, C ;

Salmon-Ceron, D ;

Carrieri, P ;

Portier, H ;

Chene, G ;

Spire, B ;

Choutet, P ;

Raffi, F ;

Morin, M .

AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2004, 16 (05) :649-661

[43] Psychological effects of HAART: A 2-year study [J].

Rabkin, JG ;

Ferrando, SJ ;

Lin, SH ;

Sewell, M ;

McElhiney, M .

PSYCHOSOMATIC MEDICINE, 2000, 62 (03) :413-422

[44] Effectiveness of step-wise intervention plan for managing nelfinavir-associated diarrhea: A pilot study [J].

Rachlis, A ;

Gill, J ;

Baril, JG ;

LeBlanc, RP ;

Trottier, B ;

MacLeod, J ;

Walmsley, S ;

Van der Vliet, W ;

Belsky, G ;

Burgoyne, R .

HIV CLINICAL TRIALS, 2005, 6 (04) :203-212

[45] Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV Cohort study [J].

Rauch, A. ;

Nolan, D. ;

Martin, A. ;

McKinnon, E. ;

Almeida, C. ;

Mallal, Simon .

CLINICAL INFECTIOUS DISEASES, 2006, 43 (01) :99-102

[46]

REISLER R, 1 INT AIDS SOC C HIV

[47] Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter [J].

Revicki, DA ;

Moyle, G ;

Stellbrink, HJ ;

Barker, C .

AIDS, 1999, 13 (07) :851-858

[48]

REVICKI DA, 1995, MED CARE, V33, pAS173

[49] Evaluating health-related wellbeing outcomes among outpatient adults with human immunodeficiency virus infection in the HAART era [J].

Saunders, DS ;

Burgoyne, RW .

INTERNATIONAL JOURNAL OF STD & AIDS, 2002, 13 (10) :683-690

[50] Impact of zidovudine plus lamivudine or zalcitabine on health-related quality of life [J].

Scott-Lennox, JA ;

Mills, RJ ;

Burt, MS .

ANNALS OF PHARMACOTHERAPY, 1998, 32 (05) :525-530

← 1 2 3 4 5 6 7 →